Drugs / Omega-3 FA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05331807 | Apr → Dec 2022 | female breast carcinoma | Universiti Sains Malaysia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omega-3 FA | “Dietary Supplement: Omega-3 FA” NCT05331807 ↗ |
| Known as | omega-3 fatty acids | “It aimed to assess the effects of omega-3 fatty acids (ω3) and vitamin D3 (VitD) supplementation on the nutritional status of newly diagnosed women with breast cancer (BC) in...” PMID 39599746 ↗ Nov 2024 |
| Modality | Other / unclassified | “Dietary Supplement: Omega-3 FA” NCT05331807 ↗ |